Dare Bioscience Inc (NAS:DARE)
$ 3.2711 -0.1 (-2.98%) Market Cap: 27.96 Mil Enterprise Value: 13.07 Mil PE Ratio: 0.21 PB Ratio: 10.45 GF Score: 34/100

Q2 2023 Dare Bioscience Inc Earnings Call Transcript

Aug 10, 2023 / 08:30PM GMT
Release Date Price: $8.58 (-2.30%)
Operator

Welcome to the conference hosted by Daré Bioscience to review the company's financial result for the quarter ended June 30, 2023, and to provide a general business update. This call is being recorded. My name is Mark, and I will be your operator today.

With us today are Sabrina Martucci Johnson, Daré's President and Chief Executive Officer; John Fair, Daré's Chief Commercial Officer; and Lisa Walters-Hoffert, Daré's Chief Financial Officer. Ms. Johnson, please proceed.

Sabrina Martucci Johnson;Bioscience
DarÃ;Inc. - President & CEO

© -

Thank you. Good afternoon and welcome to the financial results and business update call for the quarter ended June 30, 2023, for Daré Bioscience. For those of you joining us via webcast, you should be able to access presentation slides from within the webcast module. We've included the slides to provide some additional context on our portfolio that you may find helpful while you listen to the call. The slide deck is also available in the investor relations section of our website under

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot